These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

509 related articles for article (PubMed ID: 25261428)

  • 21. New synthetic drugs in addictovigilance.
    Chavant F; Boucher A; Le Boisselier R; Deheul S; Debruyne D
    Therapie; 2015; 70(2):167-89. PubMed ID: 25858573
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bath salts and other emerging toxins.
    Thornton MD; Baum CR
    Pediatr Emerg Care; 2014 Jan; 30(1):47-52; quiz 53-5. PubMed ID: 24378862
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Emergence and properties of spice and bath salts: a medicinal chemistry perspective.
    Lewin AH; Seltzman HH; Carroll FI; Mascarella SW; Reddy PA
    Life Sci; 2014 Feb; 97(1):9-19. PubMed ID: 24113072
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Case series of 21 synthetic cathinones abuse.
    Batisse A; Fortias M; Bourgogne E; Grégoire M; Sec I; Djezzar S
    J Clin Psychopharmacol; 2014 Jun; 34(3):411-3. PubMed ID: 24743721
    [No Abstract]   [Full Text] [Related]  

  • 25. [Recreational drugs: the complication's pleasure?].
    Joye F; Donzé N; Frochaux V; Niquille M; Selz Amaudruz F
    Rev Med Suisse; 2013 Aug; 9(394):1454-60. PubMed ID: 24024389
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel psychoactive substances: What educators need to know.
    Patterson ZR; Young MM; Vaccarino FJ
    Clin Pharmacol Ther; 2017 Feb; 101(2):173-175. PubMed ID: 27756105
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemistry, pharmacology, and metabolism of emerging drugs of abuse.
    Maurer HH
    Ther Drug Monit; 2010 Oct; 32(5):544-9. PubMed ID: 20683389
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute myocardial infarction, associated with the use of a synthetic adamantyl-cannabinoid: a case report.
    McIlroy G; Ford L; Khan JM
    BMC Pharmacol Toxicol; 2016 Jan; 17():2. PubMed ID: 26772803
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New and Emerging Illicit Psychoactive Substances.
    Graddy R; Buresh ME; Rastegar DA
    Med Clin North Am; 2018 Jul; 102(4):697-714. PubMed ID: 29933824
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Top 10 Facts You Need to Know About Synthetic Cannabinoids: Not So Nice Spice.
    Kemp AM; Clark MS; Dobbs T; Galli R; Sherman J; Cox R
    Am J Med; 2016 Mar; 129(3):240-4.e1. PubMed ID: 26522795
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Emerging trends in the abuse of designer drugs and their catastrophic health effects: update on chemistry, pharmacology, toxicology and addiction potential.
    Rapaka RS; Purohit V; Schnur P; Rutter J
    Life Sci; 2014 Feb; 97(1):1. PubMed ID: 24529194
    [No Abstract]   [Full Text] [Related]  

  • 32. Psychoactive 'bath salts': compounds, mechanisms, and toxicities.
    Lehner KR; Baumann MH
    Neuropsychopharmacology; 2013 Jan; 38(1):243-4. PubMed ID: 23147485
    [No Abstract]   [Full Text] [Related]  

  • 33. New psychoactive substances in substantive evidence in expert practice of the Department of Forensic Medicine, UJCM in the years 2010-2015.
    Maciów-Głąb M; Kula K; Kłys M; Rojek SD
    Arch Med Sadowej Kryminol; 2017; 67(3):178-200. PubMed ID: 29460609
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of new psychoactive substance use among emergency room patients: results from the Swedish STRIDA project.
    Helander A; Bäckberg M; Hultén P; Al-Saffar Y; Beck O
    Forensic Sci Int; 2014 Oct; 243():23-9. PubMed ID: 24726531
    [TBL] [Abstract][Full Text] [Related]  

  • 35. "Not for human consumption": a review of emerging designer drugs.
    Musselman ME; Hampton JP
    Pharmacotherapy; 2014 Jul; 34(7):745-57. PubMed ID: 24710806
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Delayed seizure-like activity following analytically confirmed use of previously unreported synthetic cannabinoid analogues.
    Schep LJ; Slaughter RJ; Hudson S; Place R; Watts M
    Hum Exp Toxicol; 2015 May; 34(5):557-60. PubMed ID: 25233895
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Baths salts, spice, and related designer drugs: the science behind the headlines.
    Baumann MH; Solis E; Watterson LR; Marusich JA; Fantegrossi WE; Wiley JL
    J Neurosci; 2014 Nov; 34(46):15150-8. PubMed ID: 25392483
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthetic drugs of abuse.
    Tamama K
    Adv Clin Chem; 2021; 103():191-214. PubMed ID: 34229850
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 'Designer drugs': update on the management of novel psychoactive substance misuse in the acute care setting.
    Smith CD; Robert S
    Clin Med (Lond); 2014 Aug; 14(4):409-15. PubMed ID: 25099844
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cumyl-PEGACLONE: A comparatively safe new synthetic cannabinoid receptor agonist entering the NPS market?
    Halter S; Angerer V; Röhrich J; Groth O; Roider G; Hermanns-Clausen M; Auwärter V
    Drug Test Anal; 2019 Feb; 11(2):347-349. PubMed ID: 30468574
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.